Cory Iverson
About
In The Last Decade
Cory Iverson
13 papers receiving 586 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 394
- Nephrology 122
- Pathology and Forensic Medicine 97
- Oncology 85
- Surgery 58
Countries citing papers authored by Cory Iverson
This map shows the geographic impact of Cory Iverson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cory Iverson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cory Iverson more than expected).
Fields of papers citing papers by Cory Iverson
This network shows the impact of papers produced by Cory Iverson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cory Iverson. The network helps show where Cory Iverson may publish in the future.
Co-authorship network of co-authors of Cory Iverson
This figure shows the co-authorship network connecting the top 25 collaborators of Cory Iverson. A scholar is included among the top collaborators of Cory Iverson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cory Iverson. Cory Iverson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 31 | |
| 4 | 24 | |
| 5 | 107 | |
| 6 | 0 | |
| 7 | 16 | |
| 8 | 46 | |
| 9 | 10 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 153 | |
| 13 | 2 | |
| 14 | RDEA119: A potent and highly selective MEK inhibitor for the treatment of cancer | 3 |
| 15 | 203 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.